Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Addition of Hypofractionated High Dose Radiation in Oligometastatic Disease - An Open Label Randomized Phase III Trial Comparing Up-front Radiation in Oligometastatic Non-small Cell Lung Cancer (NSCLC) and Systemic Treatment With Systemic Treatment Alone

NCT06141070 is registered in ClinicalTrials.gov with Vastra Gotaland Region as lead sponsor.

NCT NCT06141070
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06141070 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Addition of Hypofractionated High Dose Radiation in Oligometastatic Disease - An Open Label Randomized Phase III Trial Comparing Up-front Radiation in Oligometastatic Non-small Cell Lung Cancer (NSCLC) and Systemic Treatment With Systemic Treatment Alone
Lead sponsor
Vastra Gotaland Region
Phase
Phase 3
Overall status
Recruiting
Start date
December 1, 2023
Completion date
December 1, 2028
Enrollment
240 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

non small cell lung cancer